The city’s proposed pharmaceutical licensing fee included in the 2017 budget appears to be focused more on tracking drug marketers than revenue. As detailed in the 2017 Management Ordinance introduced this week, the application process would require a significant amount of information aimed at tracking the doctors pharmaceutical reps are meeting with and what drugs they’re pushing.